Xeris Biopharma Holdings, Inc. (XERS)

6.05 -0.07 (-1.14%) USD  |  NASDAQ  |  Mar 02, 13:09
More

Xeris Biopharma Holdings Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
IDEXX Laboratories, Inc. Upgrade
Harrow, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade